It was a pleasure to speak with Tomáš Hanke (University of Oxford, Oxford, UK) to discuss his recent work in T cell responses in HIV to inform vaccine development.
His abstract entitled: ‘Refocusing T cell responses with therapeutic vaccination strategies’ (SY09.03) was presented at the HIVR4P Virtual Conference 2021, 04 February 2021.
Part 1 of our discussion can be viewed here.
Questions:
- What are the aims of your research? (0:19)
- How can vaccines exploit vulnerability of the HIV virus? (0:50)
- Could you tell us a little about the design of the vaccines you have developed? (1:40)
- What is the current status of development of these vaccines? (2:52)
- What further studies are planned? (4:10)
Disclosures: Tomáš Hanke is a QA coinventor on a patent protecting the use of the conserved mosaic vaccines.
Support: Interview and filming supported by Touch Medical Media. Interview conducted by Katey Gabrysch.
Filmed in coverage of the HIVR4P Virtual Conference 2021.
